| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327351 | Gynecologic Oncology | 2005 | 5 Pages |
Abstract
Topotecan at this dose and schedule does not appear to have major activity in patients with advanced or recurrent uterine carcinosarcoma previously treated with chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
David Scott Miller, John A. Blessing, Jeanne Schilder, Adnan Munkarah, Yi Chun Lee,